Related Experiment Video

Updated: Sep 22, 2025

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
10:21

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Published on: September 20, 2024

546

From COVID-19 to Sarcoidosis: How Similar Are These Two Diseases?

Min Zhao1, Chang Tian1, Shan Cong1

  • 1Department of Respiratory and Critical Care Medicine, The Second Hospital of Jilin University, Changchun, China.

Frontiers in Immunology
|May 26, 2022
PubMed

Insights

This review explores connections between COVID-19 and sarcoidosis, focusing on the renin-angiotensin system, immune responses, and cell death. Understanding these links may improve severe COVID-19 treatment and sarcoidosis research.

Area of Science:

  • Immunology
  • Pulmonology
  • Pathology

Background:

  • COVID-19 (caused by SARS-CoV-2) can cause immune dysregulation and multi-organ dysfunction.
  • Sarcoidosis is an idiopathic granulomatous disease with similar clinical presentations.
  • Both conditions share overlapping clinical manifestations and can influence each other's course.

Purpose of the Study:

  • To analyze potential links between sarcoidosis and COVID-19.
  • To investigate the role of the renin-angiotensin system in SARS-CoV-2 infection.
  • To understand immune responses and cell death pathways in severe COVID-19.

Main Methods:

  • Literature review and analysis of existing research.
  • Examination of the renin-angiotensin system's role in respiratory diseases.
  • Exploration of immune system dysregulation and cell death mechanisms.

Main Results:

  • Identified shared pathways and potential interactions between sarcoidosis and COVID-19.
  • Highlighted the significance of the renin-angiotensin system in SARS-CoV-2 pathogenesis.
  • Detailed the impact on immune responses and cell death in severe cases.

Conclusions:

  • Findings offer new perspectives for COVID-19 treatment strategies.
  • Provides opportunities to advance the understanding of sarcoidosis pathogenesis.
  • Suggests potential therapeutic targets by examining shared disease mechanisms.

Keywords:
COVID-19cell death pathwaysgranulomatous diseaserenin–angiotensin systemsarcoidosis

More Related Videos

Comparing Objective Conjunctival Hyperemia Grading and the Ocular Surface Disease Index Score in Dry Eye Syndrome During COVID-1906:29

Comparing Objective Conjunctival Hyperemia Grading and the Ocular Surface Disease Index Score in Dry Eye Syndrome During COVID-19

Published on: May 25, 2022

2.4K
Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia08:05

Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia

Published on: December 19, 2020

14.3K

Related Concept Videos

COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
572
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.5K
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
34
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
3.1K
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
78
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
401